Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Holt

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
European Heart Journal|May 31, 2024
Unmeasured confounding is always unnerving: cannabis and cardiovascular riskAnders Holt, Patricia McGettigan, Morten Lamberts
European Journal of Preventive Cardiology|April 30, 2025
ADHD seems to be associated with increased cardiovascular risk - now what?Anders Holt, Morten Lamberts, Helene Gjervig Hansen
Lifetime Data Analysis|July 7, 2022
On logistic regression with right censored data, with or without competing risks, and its use for estimating treatment effectsPaul Frédéric Blanche, Anders Holt, Thomas Scheike
European Heart Journal|May 23, 2021
Temporal changes in myocardial infarction diagnostic criteria do not account for the lack of long-term beta-blocker effect on cardiovascular prognosisAnders Holt, Paul Blanche, Patricia McGettigan, et al.
Journal of Sport and Health Science|April 4, 2024
Oral fluoroquinolones and the risk of Achilles tendon rupturePeter Vibe Rasmussen, Jarl Emanuel Strange, Anders Holt
Ugeskrift for Laeger|May 14, 2025
[Risk of cardiovascular disease associated with ADHD treatment]Anders Holt, Morten Lamberts, Hanne Elberling, et al.
The American Journal of Medicine|November 30, 2025
The ReplySebastian Kinnberg Nielsen, Morten Lamberts, Anders Holt, et al.
Journal of Hypertension|July 21, 2020
Influence of inhibitors of the renin-angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patientsAnders Holt, Ikram Mizrak, Morten Lamberts, et al.
The American Journal of Medicine|September 30, 2022
The ReplyAnders Holt, Jarl E Strange, Nina Nouhravesh, et al.
American Journal of Medicine Open|April 1, 2025
The Bad Reputation of Digoxin in Atrial Fibrillation-Causality or Bias? Nationwide Nested Case-Control StudyAnders Holt, Jarl Emanuel Strange, Morten Lock Hansen, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
European Heart Journal|May 31, 2024
Unmeasured confounding is always unnerving: cannabis and cardiovascular riskAnders Holt, Patricia McGettigan, Morten Lamberts
European Journal of Preventive Cardiology|April 30, 2025
ADHD seems to be associated with increased cardiovascular risk - now what?Anders Holt, Morten Lamberts, Helene Gjervig Hansen
Lifetime Data Analysis|July 7, 2022
On logistic regression with right censored data, with or without competing risks, and its use for estimating treatment effectsPaul Frédéric Blanche, Anders Holt, Thomas Scheike
European Heart Journal|May 23, 2021
Temporal changes in myocardial infarction diagnostic criteria do not account for the lack of long-term beta-blocker effect on cardiovascular prognosisAnders Holt, Paul Blanche, Patricia McGettigan, et al.
Journal of Sport and Health Science|April 4, 2024
Oral fluoroquinolones and the risk of Achilles tendon rupturePeter Vibe Rasmussen, Jarl Emanuel Strange, Anders Holt
Ugeskrift for Laeger|May 14, 2025
[Risk of cardiovascular disease associated with ADHD treatment]Anders Holt, Morten Lamberts, Hanne Elberling, et al.
The American Journal of Medicine|November 30, 2025
The ReplySebastian Kinnberg Nielsen, Morten Lamberts, Anders Holt, et al.
Journal of Hypertension|July 21, 2020
Influence of inhibitors of the renin-angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patientsAnders Holt, Ikram Mizrak, Morten Lamberts, et al.
The American Journal of Medicine|September 30, 2022
The ReplyAnders Holt, Jarl E Strange, Nina Nouhravesh, et al.
American Journal of Medicine Open|April 1, 2025
The Bad Reputation of Digoxin in Atrial Fibrillation-Causality or Bias? Nationwide Nested Case-Control StudyAnders Holt, Jarl Emanuel Strange, Morten Lock Hansen, et al.
Pageof 5